Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nurix
Biotech
J&J innovator vaults to Valo—Chutes & Ladders
J&J innovator vaults to Valo. Alterome snags expert dealmaker as CEO. Newleos and the seven new execs.
Darren Incorvaia
,
Zoey Becker
Apr 11, 2025 8:30am
Sanofi pays Nurix $15M upfront for autoimmune degrader
Apr 2, 2025 8:10am
Flagship vet plants CEO roots at Pharming—Chutes & Ladders
Jan 24, 2025 8:30am
Roche, Vir, Neurocrine & more—Chutes & Ladders
May 31, 2024 8:30am
Gilead dives deeper into Nurix protein degrader collab
Apr 2, 2024 9:10am
Nurix gets BTK degrader back on track after FDA lifts hold
Mar 11, 2024 9:25am